MARCOS
GONZÁLEZ DÍAZ
Researcher in the period 1993-2023
Sir Charles Gairdner Hospital
Perth, AustraliaPublications in collaboration with researchers from Sir Charles Gairdner Hospital (1)
2014
-
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
British Journal of Haematology, Vol. 167, Núm. 4, pp. 466-477